Certificate of Analysis
BPC-157 / TB-500 Blend · 20mg
Laboratory Report Details
Reported laboratory entry discrepancy — clarification pending
The submitting party reports that the amount for this Wolverine (BPC-157/TB-500) blend was entered incorrectly. The original laboratory document remains available, but its component potency interpretation is disputed pending an amended report or lab clarification.
P1001
BT Labs
2026-09-11
BPC-157: 9.8 mg (49.2% as reported); TB-500: 1.1 mg (55.4% as reported)
Peptide Underground Group
BTL260821-017-009
Purity Result
99.6%
Reported purity for this specific submitted sample; purity is different from potency/content.
Lab-entry discrepancy reported by the submitting party: the amount or label-claim basis used for this BPC-157/TB-500 (Wolverine) blend was entered incorrectly. The original COA remains attached for transparency; its listed 9.8 mg / 49.2% for BPC-157 and 1.1 mg / 55.4% for TB-500 are not being presented as an undisputed assessment of the intended 10 mg + 10 mg formula. A laboratory-issued amended COA or written clarification is needed to confirm the correct amounts and percentages. This FTIR/HPLC report applies only to the Peptide Underground Group sample, lot P1001; it does not establish testing of current Veridian inventory and does not assess sterility, endotoxins or microbial contamination.
This page provides a direct link to the laboratory report for the specifically identified sample and lot. A report from another submitting organization does not establish testing or verification of Veridian's current inventory.
Direct URL
https://veridianbiosciences.com/coa/COA261327-009
Linked Compound
View Product Details